Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ADGM

Adagio Medical Holdings Inc

Dec 13 • 04:00PM ET

2.02

Dollar change -0.12
Percentage change -5.83	%

Healthcare • Medical Devices • USA • NASD

Peers: BSX STXS EW LXRX NVRO CUTR BLFS CLPT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-17.32	Insider Own	1.92%	Shs Outstand	14.54M	Perf Week	-12.17%
Market Cap	27.65M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	14.26M	Perf Month	-14.04%
Income	-19.89M	PEG	-	EPS next Q	-	Inst Own	82.69%	Short Float	0.62%	Perf Quarter	-51.90%
Sales	0.47M	P/S	58.83	EPS this Y	-	Inst Trans	8.55%	Short Ratio	1.09	Perf Half Y	-82.31%
Book/sh	5.27	P/B	0.38	EPS next Y	-	ROA	-27.06%	Short Interest	0.09M	Perf Year	-80.76%
Cash/sh	2.06	P/C	0.98	EPS next 5Y	-	ROE	-38.08%	52W Range	1.69 - 11.57	Perf YTD	-81.47%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-22.01%	52W High	-82.54%	Beta	-0.07
Dividend TTM	-	Quick Ratio	3.90	Sales past 5Y	-33.33%	Gross Margin	-286.02%	52W Low	19.53%	ATR (14)	0.33
Dividend Ex-Date	-	Current Ratio	4.42	EPS Y/Y TTM	-19537.19%	Oper. Margin	-6204.33%	RSI (14)	38.37	Volatility	9.13% 20.22%
Employees	3	Debt/Eq	0.18	Sales Y/Y TTM	-	Profit Margin	-4277.85%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.18	EPS Q/Q	-419.58%	Payout	-	Rel Volume	0.12	Prev Close	2.14
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	81.14K	Price	2.02
SMA20	-16.44%	SMA50	-23.03%	SMA200	-73.27%	Trades		Volume	9,621	Change	-5.83%

Nov-14-24 04:01PM	Adagio Medical Reports Third Quarter 2024 Results (Business Wire) +57.87% -19.14%
Nov-04-24 04:01PM	Adagio Medical to Present at the Stifel 2024 Healthcare Conference (Business Wire) +7.75%
Oct-24-24 08:30AM	Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System (Business Wire)
Oct-07-24 04:01PM	Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias (Business Wire) -7.14%
Aug-19-24 04:01PM	Adagio Medical Provides Business Updates (Business Wire)

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development and placing on the EU market of innovative ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in New York, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADGM

Adagio Medical Holdings Inc

Upgrade your FINVIZ experience